title: Subclinical isolation of Epstein—Barr viruses and immunity in women with genital herpes
metadata.name: dc.contributor.author
metadata.value: Ermolenko, Dmitriy K.
metadata.lang: -
metadata.name: dc.contributor.author
metadata.value: Zakrevskaya, Anna V.
metadata.lang: -
metadata.name: dc.contributor.author
metadata.value: Zheltakova, Irina R.
metadata.lang: -
metadata.name: dc.contributor.author
metadata.value: Ermolenko, Konstantin D.
metadata.lang: -
metadata.name: dc.contributor.author
metadata.value: Isakov, Valery A.
metadata.lang: -
metadata.name: dc.contributor.author
metadata.value: Isakov, Dmitriy V.
metadata.lang: -
metadata.name: dc.contributor.author
metadata.value: Roshchina, Natalya G.
metadata.lang: -
metadata.name: dc.date.accessioned
metadata.value: 2018-01-31T10:01:58Z
metadata.lang: -
metadata.name: dc.date.available
metadata.value: 2018-01-31T10:01:58Z
metadata.lang: -
metadata.name: dc.date.issued
metadata.value: 2017-12
metadata.lang: -
metadata.name: dc.identifier.citation
metadata.value: Ermolenko D. K., Zakrevskaya A. V., Zheltakova I. R., Ermolenko K. D., Isakov V. A., Isakov D. V., Roshchina N. G. Subclinical isolation of Epstein—Barr viruses and immunity in women with genital herpes. Vestnik SPbSU. Medicine, 2017, vol. 12, issue 4, pp. 396–406.
metadata.lang: en_GB
metadata.name: dc.identifier.other
metadata.value: 10.21638/11701/spbu11.2017.408
metadata.lang: -
metadata.name: dc.identifier.uri
metadata.value: http://hdl.handle.net/11701/9060
metadata.lang: -
metadata.name: dc.description.abstract
metadata.value: The aim of the study was to study the incidence of asymptomatic determination of Epstein-Barr viruses
  (EBV) in women with genital herpes (GH) with a recurring course of the disease depending on the stage of the process of infection and the state of vaginal microbiota. It was shown that, in the case
  of a severe course of GH, this phenomenon is observed both with recurrence of the disease (28 % of
  cases) and remission (18 % of cases). This is facilitated by the immune response that forms in patients
  with Th2 type. With an average course of GH during remission, but against a background of bacterial
  vaginosis (BV), VEB is isolated in 23 % of cases, and after its treatment in 8 %. This is explained by
  the Th2 type of immune response, and the lack of local antiviral immunity in BV. It was shown that
  a decrease in the intensity of the local and general antiviral immune response is able to “include” the
  mechanism of asymptomatic VEB secretion. Refs 23. Figs 6. Tables 2.
metadata.lang: en_GB
metadata.name: dc.language.iso
metadata.value: ru
metadata.lang: en_GB
metadata.name: dc.publisher
metadata.value: St Petersburg State University
metadata.lang: en_GB
metadata.name: dc.relation.ispartofseries
metadata.value: Vestnik of St Petersburg University. Medicine;Volume 12; Issue 4
metadata.lang: -
metadata.name: dc.subject
metadata.value: Epstein—Barr viruses
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: genital herpes
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: bacterial vaginosis
metadata.lang: en_GB
metadata.name: dc.subject
metadata.value: general and local immunity
metadata.lang: en_GB
metadata.name: dc.title
metadata.value: Subclinical isolation of Epstein—Barr viruses and immunity in women with genital herpes
metadata.lang: en_GB
metadata.name: dc.type
metadata.value: Article
metadata.lang: en_GB
resources.filename: 08-Ermolenko.pdf
resources.url: https://dspace.spbu.ru/bitstream/11701/9060/1/08-Ermolenko.pdf
resources.format: Adobe PDF
resources.size: 976,51 kB